William D. Fisher

1.6k total citations · 1 hit paper
12 papers, 1.2k citations indexed

About

William D. Fisher is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Surgery. According to data from OpenAlex, William D. Fisher has authored 12 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 8 papers in Internal Medicine and 4 papers in Surgery. Recurrent topics in William D. Fisher's work include Atrial Fibrillation Management and Outcomes (8 papers), Venous Thromboembolism Diagnosis and Management (8 papers) and Antiplatelet Therapy and Cardiovascular Diseases (2 papers). William D. Fisher is often cited by papers focused on Atrial Fibrillation Management and Outcomes (8 papers), Venous Thromboembolism Diagnosis and Management (8 papers) and Antiplatelet Therapy and Cardiovascular Diseases (2 papers). William D. Fisher collaborates with scholars based in Canada, United States and Germany. William D. Fisher's co-authors include Kenneth A. Bauer, Frank Misselwitz, Michael Gent, Louis M. Kwong, Michael R. Lassen, Alexander GG Turpie, Alice Benson, Fred D. Cushner, Bruce L. Davidson and Scott D. Berkowitz and has published in prestigious journals such as The Lancet, Blood and Journal of Bacteriology.

In The Last Decade

William D. Fisher

12 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial

2009 741 citations Alexander GG Turpie, Michael R. Lassen et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
William D. Fisher Canada	8	1.0k	987	229	137	76	12	1.2k
Horst Beckmann Germany	4	872 0.9×	940 1.0×	232 1.0×	122 0.9×	85 1.1×	5	1.1k
Gerlind Holberg Canada	6	523 0.5×	612 0.6×	296 1.3×	141 1.0×	43 0.6×	9	822
Turnly Wong Canada	6	851 0.8×	964 1.0×	351 1.5×	265 1.9×	91 1.2×	6	1.2k
L Steidl Italy	14	465 0.5×	589 0.6×	232 1.0×	178 1.3×	48 0.6×	27	890
Elise S. Eerenberg Netherlands	11	1.2k 1.2×	866 0.9×	268 1.2×	212 1.5×	35 0.5×	17	1.5k
Melissa A. Forgie Canada	9	516 0.5×	720 0.7×	262 1.1×	148 1.1×	45 0.6×	16	994
Hans Lanz United States	17	1.2k 1.2×	672 0.7×	114 0.5×	76 0.6×	26 0.3×	32	1.3k
Pierre Déguisé Canada	7	940 0.9×	376 0.4×	512 2.2×	60 0.4×	151 2.0×	10	1.2k
Bcps United States	5	724 0.7×	508 0.5×	136 0.6×	76 0.6×	47 0.6×	48	985
Betsy MacKinnon Canada	10	820 0.8×	1.2k 1.2×	568 2.5×	355 2.6×	48 0.6×	13	1.3k

Countries citing papers authored by William D. Fisher

Since Specialization

Citations

This map shows the geographic impact of William D. Fisher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William D. Fisher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William D. Fisher more than expected).

Fields of papers citing papers by William D. Fisher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William D. Fisher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William D. Fisher. The network helps show where William D. Fisher may publish in the future.

Co-authorship network of co-authors of William D. Fisher

This figure shows the co-authorship network connecting the top 25 collaborators of William D. Fisher. A scholar is included among the top collaborators of William D. Fisher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William D. Fisher. William D. Fisher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Mort, John S., et al.. (2016). Aggrecan heterogeneity in articular cartilage from patients with osteoarthritis. BMC Musculoskeletal Disorders. 17(1). 89–89. 25 indexed citations

2.

Weitz, Jeffrey I., William Semchuk, Alexander G.G. Turpie, et al.. (2015). Trends in Prescribing Oral Anticoagulants in Canada, 2008–2014. Clinical Therapeutics. 37(11). 2506–2514.e4. 118 indexed citations

3.

Fisher, William D.. (2013). Hepatitis C and the surgeon. Canadian Journal of Surgery. 56(2). 80–81. 4 indexed citations

4.

Fisher, William D.. (2011). New oral anticoagulants and outpatient prophylaxis of venous thromboembolism.. PubMed. 17(1 Suppl). S15–21. 4 indexed citations

5.

Kakkar, Ajay K., Giancarlo Agnelli, William D. Fisher, et al.. (2010). The Ultra-Low-Molecular-Weight Heparin Semuloparin for Prevention of Venous Thromboembolism In Patients Undergoing Major Abdominal Surgery. Blood. 116(21). 188–188. 20 indexed citations

6.

Turpie, Alexander GG, Michael R. Lassen, Bruce L. Davidson, et al.. (2009). Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial. The Lancet. 373(9676). 1673–1680. 741 indexed citations breakdown →

7.

Weitz, Jeffrey I., Charlie Cao, Bengt I. Eriksson, et al.. (2009). Phase II Dose-Finding Study with TAK-442, An Oral Factor Xa Inhibitor, in Patients Undergoing Elective Knee Arthroplasty.. Blood. 114(22). 170–170. 7 indexed citations

8.

Mueck, Wolfgang, Bengt I. Eriksson, Kenneth A. Bauer, et al.. (2008). Population Pharmacokinetics and Pharmacodynamics of Rivaroxaban – an Oral, Direct Factor Xa Inhibitor – in Patients Undergoing Major Orthopaedic Surgery. Clinical Pharmacokinetics. 47(3). 203–216. 209 indexed citations

9.

Eriksson, Bengt I., Kenneth A. Bauer, Lars C. Borris, et al.. (2007). Rivaroxaban for thromboprophylaxis after orthopaedic surgery: Pooled analysis of two studies. Thrombosis and Haemostasis. 97(6). 931–937. 56 indexed citations

10.

Turpie, Alexander G.G., Kenneth A. Bauer, Lars C. Borris, et al.. (2005). Thromboprophylaxis after Orthopaedic Surgery with an Oral, Direct Factor Xa Inhibitor: Pooled Results of Two Phase Iib Clinical Trials.. Blood. 106(11). 277–277. 2 indexed citations

11.

Fisher, William D., et al.. (1969). Properties of a Cell Fraction That Repairs Damage to the Cell Division Mechanism of Escherichia coli. Journal of Bacteriology. 97(2). 500–505. 19 indexed citations

12.

Fisher, William D., Mary L. Voorhess, & Lytt I. Gardner. (1963). Congenital hypothyroidism in infant following maternal I131 therapy. The Journal of Pediatrics. 62(1). 132–146. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact